Who is the CEO of Sanofi?
Who is the CEO of Sanofi?
Paul Hudson (Sep 1, 2019–)Sanofi / CEOPaul Hudson is a British businessman, and the chief executive of Sanofi, the world’s fifth largest pharmaceutical company by prescription drug sales. Wikipedia
How much does Paul Hudson make?
Hudson can collect up to 25,000 more “phantom” shares next year, based on Sanofi’s performance in 2021. On the equity side, Hudson collected about €5.7 million for 2020, bringing his total compensation for the year to €11.34 million.
Is Sanofi good company to work for?
80% of employees at Sanofi say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
Who founded Sanofi?
Jean-René Sautier
Jean-François Dehecq
Sanofi/Founders
Who is Paul Hudson partner?
Nicola HudsonPaul Hudson / Spouse (m. 2003)
Is Sanofi part of Genzyme?
Genzyme was acquired by Sanofi for $20Bn back in 2011, which is one of the biggest Biotech deals in history. For many people, Genzyme’s acquisition was considered as an ‘anomaly’ within the industry.
^ French drugmaker Sanofi sacks CEO, shares drop, Natalie Huet and Noëlle Mennella, Reuters news agency, New York 29 October 2014. Retrieved: 6 July 2015. ^ Sanofi : Sanofi Appoints Olivier Brandicourt as Chief Executive Officer, Sanofi corporate website, 19 February 2015.
Why was Sanofi’s CEO fired?
In October 2014, Sanofi’s directors fired US-resident chief executive Chris Viehbacher, blaming his alleged lack of communication with the board and poor execution of his strategy.
How many new leaders has Sanofi named to its executive committee?
PARIS – May 29, 2020 – Sanofi has named four new leaders to its Executive Committee. These appointments now complete the announced changes in February to further simplify the Company’s executive leadership team.
Why did Sanofi buy origimm biotechnology?
^ “Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy”. BioSpace. ^ “Sanofi to buy Origimm Biotechnology for acne vaccine candidate”.